KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

QuidelOrtho (QDEL) Payables (2022 - 2026)

QuidelOrtho's Payables history spans 4 years, with the latest figure at $279.4 million for Q4 2025.

  • On a quarterly basis, Payables rose 13.58% to $279.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $279.4 million, a 13.58% increase, with the full-year FY2025 number at $279.4 million, up 13.58% from a year prior.
  • Payables hit $279.4 million in Q4 2025 for QuidelOrtho, up from $213.7 million in the prior quarter.
  • Over the last five years, Payables for QDEL hit a ceiling of $294.8 million in Q4 2023 and a floor of $101.5 million in Q1 2022.
  • Historically, Payables has averaged $238.3 million across 4 years, with a median of $243.9 million in 2022.
  • Biggest five-year swings in Payables: skyrocketed 179.11% in 2023 and later fell 16.55% in 2024.
  • Tracing QDEL's Payables over 4 years: stood at $241.8 million in 2022, then grew by 21.92% to $294.8 million in 2023, then fell by 16.55% to $246.0 million in 2024, then rose by 13.58% to $279.4 million in 2025.
  • Business Quant data shows Payables for QDEL at $279.4 million in Q4 2025, $213.7 million in Q3 2025, and $218.8 million in Q2 2025.